Reed International PLC
Elsevier NV
6 December 2000
Issued on behalf of Reed International P.LC. and Elsevier NV
REED ELSEVIER INC EXTENDS HARCOURT TENDER OFFER
NEW YORK (December 6, 2000) Reed Elsevier Inc. ('Reed Elsevier') today
announced an extension of the expiration date of its tender offer for all
outstanding shares of common stock, par value $1.00 per share and all
outstanding shares of series A cumulative convertible stock, par value $1.00
per share of Harcourt General, Inc. (NYSE: H) from 12:00 midnight, New York
City time on Thursday, December 7, 2000 until 12:00 midnight, New York City
time on Monday, January 8, 2001.
The offer is being extended to accommodate the regulatory review processes and
the offer may be further extended in due course. The transaction is expected
to be completed in the first quarter of 2001, subject to the regulatory
review.
Reed Elsevier has been advised by Citibank, N.A., the Depositary for the
tender offer, that as of the close of business on December 5, 2000,
approximately 2,022,338 shares of common stock of Harcourt General, Inc. and
approximately 17,580 shares of series A cumulative convertible stock had been
validly tendered and not withdrawn pursuant to the offer.
For further information, please contact MacKenzie Partners, Inc., the
Information Agent for the tender offer, at (800) 322-2885.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.